What role does platelet‑rich plasma (PRP) play in treating low‑grade versus high‑grade partial anterior cruciate ligament (ACL) tears?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

No Role for PRP in Partial ACL Tears

Based on the most recent and highest quality evidence, PRP injection does not provide clinically meaningful benefit for partial ACL tears and should not be routinely used. The 2023 AAOS guidelines on ACL management make no recommendation for PRP use in any ACL injury context, and the best available comparative study shows no advantage 1.

Evidence Against PRP in Partial ACL Tears

Guideline Position

The 2023 AAOS Clinical Practice Guideline on ACL injuries 2 provides comprehensive recommendations for ACL management but notably omits any recommendation for PRP use in either partial or complete tears. This absence is significant—if PRP had demonstrated meaningful benefit, it would have been addressed.

Direct Evidence from Partial Tears

The most relevant study directly addressing your question 1 prospectively compared 21 patients receiving PRP injection plus physical therapy versus 19 controls receiving physical therapy alone for partial ACL tears. Key findings:

  • No difference in failure rates: 32% overall failure rate with no significant difference between groups
  • No difference in return to sport: 95% returned to sport in both groups at 4 months
  • No difference in functional outcomes: Lysholm, IKDC, and Tegner scores were equivalent
  • No difference in MRI healing: Both groups showed similar ACL signal improvement on imaging
  • Similar re-injury rates: ~30% in each group required subsequent surgery

This study demonstrates that PRP adds nothing to standard physical therapy for partial ACL tears.

What About Complete Tears or Reconstruction?

While your question focuses on partial tears, recent evidence on PRP in ACL reconstruction provides additional context:

Reconstruction Data Shows Minimal Benefit

Multiple 2026 meta-analyses 3, 4 examining PRP in ACL reconstruction found:

  • No clinically meaningful differences in pain, function, or stability
  • Some statistically significant differences (VAS scores, Lysholm scores at 6 months) were below the minimal clinically important difference (MCID)—meaning patients wouldn't notice the improvement
  • Any benefits disappeared by 12 months 3

One Uncontrolled Case Series

A 2026 retrospective case series 5 reported 82.5% success with PRP-assisted nonoperative treatment, but this study:

  • Lacked a control group (cannot determine PRP's independent contribution)
  • Had only 7 failures (insufficient for meaningful analysis)
  • Included highly selected patients
  • Combined PRP with bracing and rehabilitation (cannot isolate PRP effect)

This study is hypothesis-generating only and cannot support clinical use.

Clinical Algorithm for Partial ACL Tears

Based on the evidence, manage partial ACL tears as follows:

  1. Confirm diagnosis: Positive Lachman with firm endpoint, negative pivot-shift, <3mm side-to-side difference on KT-1000
  2. Initiate structured physical therapy focusing on:
    • Quadriceps strengthening
    • Neuromuscular control
    • Sport-specific training
  3. Do NOT add PRP—it provides no additional benefit
  4. Monitor for failure (clinical instability requiring reconstruction):
    • Occurs in ~30% of cases
    • Typically manifests at 5-8 months
    • More common in younger patients, complete tears, and mid-substance tears 5, 1

Critical Pitfalls to Avoid

  • Don't be swayed by statistical significance alone: Recent studies show statistically significant differences that fall below MCID thresholds 4
  • Don't extrapolate reconstruction data to partial tears: These are different injury patterns with different healing potential
  • Don't use PRP as a substitute for proper rehabilitation: The control groups in studies achieved excellent outcomes with PT alone 1
  • Don't delay reconstruction in appropriate candidates: Younger, active patients with complete tears may benefit from early reconstruction to prevent meniscal damage 2

Quality of Evidence Assessment

The evidence against PRP is moderate to high quality:

  • 2023 AAOS guidelines (highest authority) make no recommendation for PRP 2
  • Direct RCT evidence in partial tears shows no benefit 1
  • Multiple 2026 meta-analyses confirm lack of clinically meaningful benefit 3, 4
  • GRADE assessments rate the evidence as LOW to VERY LOW quality 4

The burden of proof lies with those advocating for PRP use, and that burden has not been met.

References

Related Questions

What adverse effects are observed within the first three weeks of initiating trifluridine/tipiracil (TAS‑102) combined with bevacizumab?
In an elderly patient being treated with galantamine (Galsya SR 8 mg) for Alzheimer’s disease, can it be combined with tramadol?
How should I manage a patient who is not vomiting, can tolerate mild oral fluids, but is passing minimal semisolid stools with each bowel movement?
What is leprosy (Hansen disease)?
Is dyspnea accompanied by hemoptysis a common adverse effect of the trifluridine/tipiracil plus bevacizumab regimen?
What are the possible complications of scrub typhus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.